多维度协同护理对带状疱疹后遗神经痛患者负性情绪及疼痛状况改善的影响

目的探讨多维度协同护理对带状疱疹后遗神经痛患者的负性情绪控制和疼痛改善情况的效果。方法选取医院2019年10月—2020年2月带状疱疹后遗神经痛患者48例作为研究对象,按组间基本特征匹配原则分为对照组和观察组,各24例,对照组予以常规护理,观察组予以多维度协同护理。于干预前后进行评估,比较两组患者负面情绪、疼痛情况和护理效果。结果观察组患者干预后的焦虑、抑郁评分和疼痛评分低于对照组,观察组的护理有效率高于对照组,两组间比较差异均有统计学意义(P<0.05)。结论多维度协同护理能够有效缓解带状疱疹后遗神经痛患者焦躁和抑郁等负面情绪及疼痛情况。     

团队式疼痛共控法对顽固性带状疱疹后遗神经痛患者的影响分析

目的观察团队式疼痛共控法对顽固性带状疱疹后遗神经痛患者的影响效果。方法选择2020年7月至2021年6月收治于盐城市大丰人民医院的带状疱疹顽固性后遗神经痛患者86例为研究对象，其中2020年7月至12月收治的43例为对照组，2021年1月至6月收治的43例为观察组，对照组予以常规护理，观察组接受团队式疼痛共控法干预，比较两组干预后的疼痛评分、焦虑抑郁评分、生活质量影响度评分。结果干预后观察组疼痛评分、焦虑抑郁评分、生活质量影响度评分均低于对照组（均P＜0.05）。结论采用团队式疼痛共控法对顽固性带状疱疹后遗神经痛患者施加干预，可显著提高疼痛管理效果，改善患者负面情绪与生活质量。     

eCASH理念应用于带状疱疹神经痛病人镇痛管理的效果评价

[目的]评价基于eCASH理念的综合干预对带状疱疹神经痛病人镇痛的效果。[方法]选择74例带状疱疹神经痛病人为研究对象,按随机数字表法分为eCASH组和对照组,各37例。对照组进行常规护理干预,eCASH组在对照组的基础上实施eCASH干预方案。比较两组病人干预前后疼痛评分、负性情绪评分及干预后睡眠质量评分。[结果]干预2周后两组病人NRS评分均明显低于干预前(P0.05),且eCASH组低于对照组(P0.05);干预后,两组病人焦虑自评量表(SAS)、抑郁自评量表(SDS)评分均明显低于干预前(P0.05),且eCASH组低于对照组(P0.01);干预后,eCASH组病人PSQI评分明显低于对照组(P0.01)。[结论]将eCASH理念应用于带状疱疹神经痛病人镇痛管理中,能更好地帮助病人控制疼痛,缓解病人负性情绪,改善睡眠质量。     

认知行为干预在B超引导下神经阻滞治疗带状疱疹后遗神经痛中的应用

[目的]探讨认知行为干预在B超引导下神经阻滞治疗带状疱疹后遗神经痛(PHN)中的应用效果。[方法]根据随机数字表法将2017年1月—2017年12月收治的92例B超引导下神经阻滞治疗PHN病人分为观察组及对照组各46例,对照组治疗期间行常规性护理干预,观察组治疗期间对其实施认知行为干预。采用治疗依从性调查问卷评价两组病人治疗依从性,采用视觉模拟评分法(VAS)评价两组病人疼痛情况,采用自拟的PHN病人疾病知识调查问卷评价病人疾病知识知晓情况,采用病人满意度调查问卷评价病人治疗满意率,比较两组病人并发症发生率,分别于干预前后采用焦虑自评量表(SAS)、抑郁自评量表(SDS)和简易生活质量量表(SF-36)评价两组病人负性情绪及生活质量。[结果]观察组治疗依从率、疼痛缓解率、疾病知识知晓率、治疗满意率均高于对照组(P0.05),并发症发生率低于对照组(P0.05)。观察组干预后焦虑自评量表(SAS)评分、抑郁自评量表(SDS)评分、视觉模拟评分(VAS)均低于对照组(P0.05),生活质量评分高于对照组(P0.05)。[结论]认知行为干预能有效减轻B超引导下神经阻滞治疗带状疱疹后遗神经痛病人负性情绪,提高病人疾病知识及治疗效果,改善病人生活质量。     

疼痛护理干预在带状疱疹后遗神经痛患者中的应用效果

目的 分析疼痛护理干预在带状疱疹后遗神经痛（PHN）患者中的应用效果。方法 选取 2021 年 4 月至 2022 年 8 月期间 本院收治的 80 例带状疱疹后遗神经痛患者作为研究对象。根据随机数字表法将患者分为对照组和观察组,每组 40 例。对照组 给予常规护理措施;观察组给予疼痛护理干预。分析对比两组的疼痛情况、心理状态以及睡眠质量。结果 护理 14d 后,观察 组的数字评定量表（NRS）评分显著低于对照组,疼痛发作频率显著低于对照组（P<0.05）。观察组的 PSQI 评分显著低于对照 组（P<0.05）。护理后,观察组的汉密顿焦虑量表（HAMA）评分和汉密顿抑郁量表（HAMD）评分均显著低于对照组（P<0.05）。 结论 疼痛护理干预应用于带状疱疹后遗神经痛患者的护理中,能改善患者的焦虑抑郁情绪,缓解患者的神经痛症状,提高睡 眠质量。     

个性化护理干预对老年带状疱疹患者疼痛症状及满意度的影响

目的:探讨个性化护理干预对老年带状疱疹患者疼痛症状及满意度的影响。方法:将80例老年带状疱疹患者按随机数字法分为观察组和对照组各40例,对照组接受常规护理,观察组采取个性化护理干预;比较两组护理前后视觉模拟疼痛评分(VAS)、止疱时间、后遗神经痛发生率、疼痛症状消失时间、疼痛症状减轻时间及护理满意度。结果:护理后第2周、3周、4周观察组VAS评分显著低于对照组(P0.05);观察组止疱时间、后遗神经痛发生率、疼痛症状消失时间、减轻时间均显著低于对照组(P0.05),护理满意度显著高于对照组(P0.05)。结论:在老年带状疱疹患者中应用个性化护理干预,可降低后遗神经痛发生风险,有效减轻疼痛,缩短疼痛缓解及消失时间,提高护理满意度。     

疼痛护理干预对带状疱疹后遗神经痛患者视觉模拟评分及睡眠质量的影响

目的:分析疼痛护理干预在带状疱疹后遗神经痛治疗中的应用效果及对患者疼痛程度和睡眠质量的影响。方法:选取2019年1月至2019年12月来安徽省蚌埠市第一人民医院接受带状疱疹后遗神经痛治疗的患者60例作为研究对象,随机分为观察组和对照组,每组30例。对照组患者接受护理,观察组患者接受疼痛护理干预,比较2组患者护理前后疼痛程度、睡眠质量、生命质量和护理满意率。结果:护理后观察组患者VAS评分和PSQI评分均明显低于对照组,SF-36评分明显高于对照组(P<0.05);观察组护理满意率为93.33%,对照组为80.00%,P<0.05。结论:疼痛护理干预可有效改善带状疱疹后遗神经痛患者的疼痛程度,对于提高患者的睡眠质量和护理满意率效果显著,值得推广应用。     

金黄膏外敷联合情志顺势心理干预对带状疱疹后遗神经痛病人疼痛程度及睡眠质量的影响

目的:探究金黄膏外敷联合情志顺势心理干预对带状疱疹后遗神经痛(PHN)病人疼痛程度及睡眠质量的影响。方法:选取2020年3月—2023年2月医院收治的80例PHN病人为研究对象,按照随机数字表法分为对照组、观察组,每组40例。对照组接受常规干预,观察组在常规干预的基础上接受金黄膏外敷联合情志顺势心理干预,干预1个月;于干预前后比较两组病人疼痛程度[数字疼痛评分表(NRS)评分]、心理状况[焦虑自评量表(SAS)、抑郁自评量表(SDS)评分]、睡眠质量[匹兹堡睡眠质量指数(PSQI评分)]。结果:干预2、4周观察组病人NRS评分低于对照组(P<0.05);干预后两组病人SAS、SDS、PSQI评分均下降,且观察组较对照组低(P<0.05)。结论:金黄膏外敷联合情志顺势心理干预能够减轻病人疼痛度,改善病人心理状况,提高病人睡眠质量。     

艾灸联合穴位按摩对带状疱疹后遗神经痛的影响

[目的]探讨艾灸联合穴位按摩对带状疱疹后遗神经痛的影响。[方法]将64例带状疱疹后遗神经痛病人按照随机数字表法分为观察组(32例)和对照组(32例),对照组给予常规治疗和护理,观察组在常规治疗和护理基础上加以艾灸和穴位按摩,观察并比较两组病人疼痛改善程度、临床治疗有效率及治疗2个月后复发率。[结果]观察组疼痛改善度优于对照组(P0.05);观察组临床治疗总有效率明显高于对照组(P0.05)。[结论]艾灸联合穴位按摩治疗带状疱疹后遗神经痛临床疗效较好,能有效缓解病人疼痛。     

综合护理干预在女性结核性盆腔炎病人中的应用效果

[目的]观察综合护理干预在女性结核性盆腔炎病人中的应用效果。[方法]将184例女性结核性盆腔炎病人分为对照组和观察组,对照组给予常规护理,观察组在常规护理的基础上给予综合护理干预,观察两组病人疼痛评分、焦虑评分、抑郁评分情况及对疾病认知程度。[结果]干预后观察组病人疼痛、焦虑及抑郁评分明显低于对照组,观察组病人对疾病认知程度(88.04%)明显高于对照组(59.78%),观察组治疗依从性优于对照组,经比较差异均有统计学意义(P0.05)。[结论]综合护理干预能有效缓解病人疼痛,缓解病人焦虑、抑郁情绪,提高病人对疾病知识知晓率及治疗依从性。     

阿片类药物在慢性非癌性疼痛中的应用

目的:回顾性分析卡马西平和加巴喷丁治疗原发性三叉神经痛、带状疱疹以及带状疱疹后遗神经痛的疗效、安全性和不良反应。方法:102位患者进入本研究,比较卡马西平或加巴喷丁治疗前后患者疼痛强度的改变和对睡眠影响的改善;依据药物分类,比较两种药物的副作用和不良反应。结果:卡马西平治疗原发性三叉神经痛起效较加巴喷丁快,二者长期疗效相当;加巴喷丁治疗带状疱疹和带状疱疹后神经痛的疗效优于卡马西平;疗效随治疗时间的延长而增加。卡马西平的副作用和不良反应事件发生率较加巴喷丁高。结论:抗癫痫药物卡马西平和加巴喷丁是治疗神经病理性疼痛的有效药物,可以改善患者的睡眠,但副作用和不良反应发生率高。     

带状疱疹后神经痛患者疼痛护理研究进展

带状疱疹后神经痛是带状疱疹最常见的并发症,严重影响患者生活质量.本文从带状疱疹后神经痛的概述、临床表现、疼痛评估工具和疼痛护理的研究进展进行综述,以期为临床更有效地帮助带状疱疹后神经痛患者缓解疼痛、提高生活质量提供借鉴和参考.     

接纳承诺疗法在中老年带状疱疹后神经痛患者中的应用效果

目的探讨对中老年带状疱疹后神经痛患者实施接纳承诺疗法干预的效果。方法采用便利抽样方法,选取2019年1—6月在山西省太原市某三级甲等医院疼痛科就诊的带状疱疹后神经痛中老年患者70例作为研究对象,根据随机数字表将其分为观察组与对照组,每组各35例。对照组沿用常规心理护理干预,观察组患者实施接纳承诺疗法干预。分别采用中文版简易慢性疼痛接受问卷(CPAQ-8)、简化Mc Gill疼痛问卷(SF-MPQ)和医院焦虑抑郁量表(HADS)在患者干预前后进行问卷调查,评估疼痛接纳程度、疼痛程度以及焦虑、抑郁程度。结果干预前,两组患者的CPAQ-8、SF-MPQ和HADS得分差异均无统计学意义(P>0.05)。干预后,观察组患者CPAQ-8得分高于对照组,SF-MPQ、HADS得分低于对照组,两组比较差异有统计学意义(P<0.05)。结论接纳承诺疗法可有效提升中老年带状疱疹后神经痛患者对疼痛的接纳程度,减轻疼痛程度,使疼痛带来的焦虑、抑郁情绪得到改善,值得临床推广使用。     

Management of herpes zoster (shingles) and postherpetic neuralgia

Herpes zoster (commonly referred to as "shingles") and postherpetic neuralgia result from reactivation of the varicella-zoster virus acquired during the primary varicella infection, or chickenpox. Whereas varicella is generally a disease of childhood, herpes zoster and post-herpetic neuralgia become more common with increasing age. Factors that decrease immune function, such as human immunodeficiency virus infection, chemotherapy, malignancies and chronic corticosteroid use, may also increase the risk of developing herpes zoster. Reactivation of latent varicella-zoster virus from dorsal root ganglia is responsible for the classic dermatomal rash and pain that occur with herpes zoster. Burning pain typically precedes the rash by several days and can persist for several months after the rash resolves. With postherpetic neuralgia, a complication of herpes zoster, pain may persist well after resolution of the rash and can be highly debilitating. Herpes zoster is usually treated with orally administered acyclovir. Other antiviral medications include famciclovir and valacyclovir. The antiviral medications are most effective when started within 72 hours after the onset of the rash. The addition of an orally administered corticosteroid can provide modest benefits in reducing the pain of herpes zoster and the incidence of postherpetic neuralgia. Ocular involvement in herpes zoster can lead to rare but serious complications and generally merits referral to an ophthalmologist. Patients with postherpetic neuralgia may require narcotics for adequate pain control. Tricyclic antidepressants or anticonvulsants, often given in low dosages, may help to control neuropathic pain. Capsaicin, lidocaine patches and nerve blocks can also be used in selected patients.     

神经妥乐平治疗带状疱疹后遗神经痛的临床研究

目的:研究神经妥乐平治疗带状疱疹后遗神经疼痛的疗效、方法和安全性.方法:将患者随机分为对照组和神经妥乐平不同剂量组(3.8u/日,10.8u/日),疗程14天.结果:神经妥乐平使带状疱疹后遗神经痛明显改善,并具有快速起效、长时间止痛作用.尤其神经妥乐平10.8u/日组,疗效显著.结论:神经妥乐平是治疗带状疱疹后遗神经痛有效和安全药物.     

Pain treatment of herpes zoster

Reactivation of varicella-zoster virus causes herpes zoster, which accompanies severe pain in most patients. Treatment of pain is mandatory in herpes zoster. Pain caused by herpes zoster is classified as acute herpetic pain and postherpetic neuralgia. The mechanisms and treatments for the two pains are different. Acute herpetic pain is inflammatory and nociceptive one. Treatment for acute herpetic pain includes antiviral drugs, non-steroidal anti-inflammatory drugs, opioids, and sympathetic nerve blockade. Postherpetic neuralgia is a neuropathic pain and requires antidepressants, anticonvulsants, and anti-arrhythmic drugs to relieve the pain. Topical application of capsaicin and local anesthetics may benefit some patients with postherpetic neuralgia.     

Patients' experiences of herpes zoster and postherpetic neuralgia

The purpose of the study was to investigate retrospectively whether patients ( n = 73) who had suffered another disease and/or experienced psychosocial stress at the time of the onset of herpes zoster had experienced a more severe clinical course of herpes zoster, and were more subject to the development of postherpetic neuralgia than other patients ( n =45) with herpes zoster The interview questionnaire included questions about changes in the patients' daily lives due to neuralgia, and their current living circumstances Significantly more of the patients who had had another disease and/or psychosocial stress at the time of the onset of herpes zoster reported severe pain during the acute phase of herpes zoster They also reported pain to a greater extent at the time of the interview and mentioned that their lives had changed owing to postherpetic neuralgia More of these patients reported that their habits and activities had been negatively affected and they also experienced their current situation as unsatisfactory These results must, however, be interpreted with caution as the patients' recollection of other diseases and/or psychosocial stress and the patients' current mood due to postherpetic neuralgia at the time of the interview may have influenced the memory and the answers     

Herpes zoster and postherpetic neuralgia: prevention and management

The recognizable appearance and the dermatomal distribution of herpes zoster lesions usually enable a clinical diagnosis to be made easily. Herpes zoster and postherpetic neuralgia occur mainly in older patients. The role of the varicella vaccine in preventing herpes zoster is uncertain, but is being studied. There is evidence to support using antiviral therapy and possibly low-dose tricyclic antidepressants to prevent postherpetic neuralgia. There is good evidence that treating herpes zoster with antiviral medication is beneficial, particularly in patients older than 50 years with severe outbreaks. The use of steroids has an unfavorable risk-benefit ratio. In patients who develop postherpetic neuralgia, there is good evidence to support treatment with gabapentin and tricyclic antidepressants. More evidence for treatment with capsaicin cream, lidocaine patch, and opioids is needed. Intrathecal methylprednisolone is an option for patients with persistent pain.     

局部紫外线联合阿昔洛韦治疗带状疱疹的疗效观察

目的观察局部紫外线照射联合阿昔洛韦治疗带状疱疹的临床疗效。方法138例带状疱疹患者分为2组。治疗组用阿昔洛韦口服治疗加局部紫外线照射;对照组单用阿昔洛韦治疗带状疱疹。结果治疗组有效率（97．92％）明显高于对照组（P〈0．05）,带状疱疹后遗神经痛发生率亦比对照组明显降低。结论局部紫外线联合阿昔洛韦治疗带状疱疹起效快,疗程短,疗效显著,且能防止后神经痛的发生。